Please use this identifier to cite or link to this item:
https://doi.org/10.1111/cas.13424
Title: | PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer | Authors: | Mimura K. Teh J.L. Okayama H. Shiraishi K. Kua L.-F. Koh V. Smoot D.T. Ashktorab H. Oike T. Suzuki Y. Fazreen Z. Asuncion B.R. Shabbir A. Yong W.-P. So J. Soong R. Kono K. |
Keywords: | CD8 gastric cancer IFN-? PD-L1 TILs |
Issue Date: | 1-Jan-2018 | Publisher: | Blackwell Publishing Ltd | Citation: | Mimura K., Teh J.L., Okayama H., Shiraishi K., Kua L.-F., Koh V., Smoot D.T., Ashktorab H., Oike T., Suzuki Y., Fazreen Z., Asuncion B.R., Shabbir A., Yong W.-P., So J., Soong R., Kono K. (2018-01-01). PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer. Cancer Science 109 (1) : 43-53. ScholarBank@NUS Repository. https://doi.org/10.1111/cas.13424 | Abstract: | Despite multidisciplinary treatment for patients with advanced gastric cancer, their prognosis remains poor. Therefore, the development of novel therapeutic strategies is urgently needed, and immunotherapy utilizing anti-programmed death 1/-programmed death ligand-1 mAb is an attractive approach. However, as there is limited information on how programmed death ligand-1 is upregulated on tumor cells within the tumor microenvironment, we examined the mechanism of programmed death ligand-1 regulation with a particular focus on interferon gamma in an in爒itro setting and in clinical samples. Our in爒itro findings showed that interferon gamma upregulated programmed death ligand-1 expression on solid tumor cells through the JAK-signal transducer and activator of transcription pathway, and impaired the cytotoxicity of tumor antigen-specific CTL against tumor cells. Following treatment of cells with anti-programmed death ligand-1 mAb after interferon gamma-pre-treatment, the reduced anti-tumor CTL activity by interferon gamma reached a higher level than the non-treatment control targets. In contrast, programmed death ligand-1 expression on tumor cells also significantly correlated with epithelial-mesenchymal transition phenotype in a panel of solid tumor cells. In clinical gastric cancer samples, tumor membrane programmed death ligand-1 expression significantly positively correlated with the presence of CD8-positive T cells in the stroma and interferon gamma expression in the tumor. The results suggest that gastric cancer patients with high CD8-positive T-cell infiltration may be more responsive to anti-programmed death 1/-programmed death ligand-1 mAb therapy. � 2017 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. | Source Title: | Cancer Science | URI: | http://scholarbank.nus.edu.sg/handle/10635/146666 | ISSN: | 13479032 | DOI: | 10.1111/cas.13424 |
Appears in Collections: | Elements Staff Publications |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
cas.13424.pdf | 1.51 MB | Adobe PDF | OPEN | None | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.